I.Introduction

II. PAP Smear/HPV Worldwide Market and Technology Overview
A. PAP Smear/HPV: Clinical Significance
and Laboratory Practices

B. Instrumentation Review And Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. J&J Vitros ECi/ECiQ
14. J&J Vitros 3600
15. J&J Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max
27. Siemens Dimension Vista 500
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500

C. Current and Emerging Technologies
1.Monoclonal and Polyclonal Antibodies
2.Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation

H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy

D. Personal Testing

III. France: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

IV. Germany: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

VI. Spain: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares

VII. U.K.: Test Volume and Diagnostics Sales Forecast
by Market Segment, Supplier Sales and Market Shares
VIII.Design Criteria for Decentralized Testing Products

IX. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts

D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor

X. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XI. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics/Theradiag
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix/Clinical Genomics
- Enzo Biochem
- Exact Sciences
- Fujirebio/Innogenetics
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Life Technologies
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Tosoh
- Veridex
- Vermillion
- Wako Pure Chemicals
- Wallac/PE
- Zila

List of Tables
Major Companies Developing or Marketing Pap Smear/HPV Tests
France
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Germany
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Germany
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Italy
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Italy
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
Spain
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
Spain
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers
U.K.
PAP Smear Test Volume and Diagnostics Sales
by Market Segment
U.K.
Papillomavirus(HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
PAP Smear/HPV Diagnostic Testing Market
Sales and Shares of Leading Suppliers